COVID-19 / FluA, B / RSV test without extraction from Seegene now available in Europe


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ COVID-19 / FluA, B / RSV test without extraction from Seegene now available in Europe
The company also expressed confidence that the addition of the new feature will enable labs around the world to use test kits more widely

South Korean biotechnology company Seegene Inc., a molecular diagnostics company, announced recently that its Allplex  SARS-CoV-2 / FluA / FluB / RSV assays for extraction-free use are now available are available in Europe. Seegene had already received the CE-IVD mark for this product in September so that it could be launched across Europe from October.

Seegene's Allplex SARS-CoV-2 / FluA / FluB / RSV Assay is a real-time RT-PCR assay that can simultaneously detect and distinguish eight target genes, including influenza A / B and RSV A / B, and three different ones COVID-19 targets (S-Gen, RdRP-Gen and N-Gen). This makes it the first and only test worldwide with this ability. The assay also includes two internal control targets (endogenous and exogenous) in the same reaction tube, allowing verification of the entire test procedure and proper sampling without affecting the accuracy of the test results.

The extraction-free use of the Allplex SARS-CoV-2 / FluA / FluB / RSV assay is of great importance for combating the COVID-19 pandemic, as flu and colds are also rampant in winter. Whereas extraction devices were previously required to carry out molecular diagnostic tests, thanks to the option for extraction-free use, laboratories without this equipment can now examine samples for COVID-19 in an even faster throughput time (TAT). This technological advance not only saves time and money when testing for the new type of coronavirus, it also enables laboratories that previously had no testing facility at all to carry out mass tests.

A representative from Seegene expressed his hope that the extraction-free application of the assay would help bring the pandemic in Europe under control quickly. The company also expressed confidence that the addition of the new feature will enable labs around the world to use test kits more widely. According to Worldometer, the number of people infected with COVID-19 worldwide was 17,148,406 in November alone, with the numbers being highest in the US and Europe.

Tags : #SeegeneInc #LatestNewsonSeegeneInc21stDec #LatestPharmaNews21stDec #COVID-19Pandemic #Extraction-freeCOVIDTest #SouthKorea #UnitedStates #Europe

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026